176 related articles for article (PubMed ID: 25625510)
21. Willingness to Pay for One Additional Quality Adjusted Life Year: A Population Based Survey from China.
Ye Z; Abduhilil R; Huang J; Sun L
Appl Health Econ Health Policy; 2022 Nov; 20(6):893-904. PubMed ID: 35934772
[TBL] [Abstract][Full Text] [Related]
22. Willingness to pay per quality-adjusted life year for life-saving treatments in Thailand.
Nimdet K; Ngorsuraches S
BMJ Open; 2015 Oct; 5(10):e008123. PubMed ID: 26438135
[TBL] [Abstract][Full Text] [Related]
23. Disentangling WTP per QALY data: different analytical approaches, different answers.
Gyrd-Hansen D; Kjaer T
Health Econ; 2012 Mar; 21(3):222-37. PubMed ID: 21254305
[TBL] [Abstract][Full Text] [Related]
24. Willingness-to-Pay for One Quality-Adjusted Life-Year: A Population-Based Study from Iran.
Lankarani KB; Ghahramani S; Moradi N; Shahraki HR; Lotfi F; Honarvar B
Appl Health Econ Health Policy; 2018 Dec; 16(6):837-846. PubMed ID: 30123949
[TBL] [Abstract][Full Text] [Related]
25. Determination of Cost-Effectiveness Threshold for Health Care Interventions in Malaysia.
Lim YW; Shafie AA; Chua GN; Ahmad Hassali MA
Value Health; 2017 Sep; 20(8):1131-1138. PubMed ID: 28964445
[TBL] [Abstract][Full Text] [Related]
26. The value of a QALY towards the end of life and its determinants: Experimental evidence.
Fischer B; Telser H; Zweifel P; von Wyl V; Beck K; Weber A
Soc Sci Med; 2023 Jun; 326():115909. PubMed ID: 37121067
[TBL] [Abstract][Full Text] [Related]
27. The value of dementia care towards the end of life-A contingent valuation study.
Bhattarai N; Mason H; Kernohan A; Poole M; Bamford C; Robinson L; Vale L
Int J Geriatr Psychiatry; 2020 May; 35(5):489-497. PubMed ID: 31912572
[TBL] [Abstract][Full Text] [Related]
28. Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation.
King JT; Tsevat J; Lave JR; Roberts MS
Med Decis Making; 2005; 25(6):667-77. PubMed ID: 16282217
[TBL] [Abstract][Full Text] [Related]
29. QALY-type preference and willingness-to-pay among end-of-life patients with cancer treatments: a pilot study using discrete choice experiment.
Yin Y; Peng Q; Ma L; Dong Y; Sun Y; Xu S; Ding N; Liu X; Zhao M; Tang Y; Mei Z; Shao H; Yan D; Tang W
Qual Life Res; 2024 Mar; 33(3):753-765. PubMed ID: 38079024
[TBL] [Abstract][Full Text] [Related]
30. Value of a QALY and VSI estimated with the chained approach.
Olofsson S; Gerdtham UG; Hultkrantz L; Persson U
Eur J Health Econ; 2019 Sep; 20(7):1063-1077. PubMed ID: 31172400
[TBL] [Abstract][Full Text] [Related]
31. Estimating the monetary value of a Quality-Adjusted Life-Year in Quebec.
Kouakou CRC; He J; Poder TG
Eur J Health Econ; 2024 Jul; 25(5):787-811. PubMed ID: 37656261
[TBL] [Abstract][Full Text] [Related]
32. Study of Patients' Willingness to Pay for a Cure of Chronic Obstructive Pulmonary Disease in Taiwan.
Chen YT; Ying YH; Chang K; Hsieh YH
Int J Environ Res Public Health; 2016 Mar; 13(3):. PubMed ID: 26938547
[TBL] [Abstract][Full Text] [Related]
33. Willingness to pay for quality and length of life gains in end of life patients of different ages.
Reckers-Droog V; van Exel J; Brouwer W
Soc Sci Med; 2021 Jun; 279():113987. PubMed ID: 33975052
[TBL] [Abstract][Full Text] [Related]
34. Is there a kink in consumers' threshold value for cost-effectiveness in health care?
O'Brien BJ; Gertsen K; Willan AR; Faulkner LA
Health Econ; 2002 Mar; 11(2):175-80. PubMed ID: 11921315
[TBL] [Abstract][Full Text] [Related]
35. Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?
Thavorncharoensap M; Teerawattananon Y; Natanant S; Kulpeng W; Yothasamut J; Werayingyong P
Clinicoecon Outcomes Res; 2013; 5():29-36. PubMed ID: 23345984
[TBL] [Abstract][Full Text] [Related]
36. Willingness to pay for one quality-adjusted life year in Iran.
Moradi N; Rashidian A; Nosratnejad S; Olyaeemanesh A; Zanganeh M; Zarei L
Cost Eff Resour Alloc; 2019; 17():4. PubMed ID: 30867654
[TBL] [Abstract][Full Text] [Related]
37. Exploring the willingness to pay for a quality-adjusted life-year in the state of Penang, Malaysia.
Shafie AA; Lim YW; Chua GN; Hassali MA
Clinicoecon Outcomes Res; 2014; 6():473-81. PubMed ID: 25364267
[TBL] [Abstract][Full Text] [Related]
38. Testing the convergent validity of the contingent valuation and travel cost methods in valuing the benefits of health care.
Clarke PM
Health Econ; 2002 Mar; 11(2):117-27. PubMed ID: 11921310
[TBL] [Abstract][Full Text] [Related]
39. The willingness to pay for in vitro fertilization: a pilot study using contingent valuation.
Neumann PJ; Johannesson M
Med Care; 1994 Jul; 32(7):686-99. PubMed ID: 8028404
[TBL] [Abstract][Full Text] [Related]
40. International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?
Shiroiwa T; Sung YK; Fukuda T; Lang HC; Bae SC; Tsutani K
Health Econ; 2010 Apr; 19(4):422-37. PubMed ID: 19382128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]